Encore Presentations

Filters

Year

Meeting

Topic

Faculty

Access
Open to Guests

CME Credit
With Credit Only

313 Results

In Everyone’s Best Interest: Protecting Patients and Prescribers from the Consequences of Neglected Tardive Dyskinesia Desiree M Matthews, MSN, PMHNP-BC CME credit: 1.00 Get Started
Not Your Grandpa’s Antipsychotic: Optimizing Treatment for Schizophrenia Utilizing Novel Muscarinic Treatment Strategies Leslie Citrome, MD, MPH CME credit: 1.00 Get Started
A More Tailored and Swift Approach? Using Clinical Endophenotypes to Address Major Depressive Disorder in All of Its Variations Roger McIntyre, MD, FRCPC CME credit: 1.00 Get Started
Musc-y With a Chance of Glu: Advances in Our Understanding of Cortical Networks Involved in Cognitive Impairment Associated With Schizophrenia Andrew J Cutler, MD; Roger McIntyre, MD, FRCPC CME credit: 1.00 Get Started
Putting a SDA-PA to “Antipsychotic” Nomenclature: Improving Patient Engagement and Outcomes in the Pharmacological Treatment of Psychiatric Issues Joseph F. Goldberg, MD CME credit: 1.00 Get Started
From Unipolar to Bipolar (and Everything In Between): Identifying and Treating Depression Across the Entire Mood Disorders Spectrum Andrew J Cutler, MD; Joseph F. Goldberg, MD CME credit: 1.00 Get Started
Bring Your “A” Game: Screening For and Treating Depression With Mixed Features Manpreet K Singh, MD, MS CME credit: 0.75 Get Started
Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders Roger McIntyre, MD, FRCPC CME credit: 1.00 Get Started
If You Musc: Modulation of Muscarinic Receptors in the Treatment of Schizophrenia Hara Ella Oyedeji, CRNP, PMHNP, MSN, MED CME credit: 1.00 Get Started
Outside the Box: Upstream Muscarinic Modulation of Downstream Dopamine Jonathan M Meyer, MD CME credit: 1.00 Get Started
1 2 3 4 5 6 7 8 9 10 ...

In Everyone’s Best Interest: Protecting Patients and Prescribers from the Consequences of Neglected Tardive Dyskinesia

Desiree M Matthews, MSN, PMHNP-BC CME credit: 1.00

Get Started

Not Your Grandpa’s Antipsychotic: Optimizing Treatment for Schizophrenia Utilizing Novel Muscarinic Treatment Strategies

Leslie Citrome, MD, MPH CME credit: 1.00

Get Started

A More Tailored and Swift Approach? Using Clinical Endophenotypes to Address Major Depressive Disorder in All of Its Variations

Roger McIntyre, MD, FRCPC CME credit: 1.00

Get Started

Musc-y With a Chance of Glu: Advances in Our Understanding of Cortical Networks Involved in Cognitive Impairment Associated With Schizophrenia

Andrew J Cutler, MD; Roger McIntyre, MD, FRCPC CME credit: 1.00

Get Started

Putting a SDA-PA to “Antipsychotic” Nomenclature: Improving Patient Engagement and Outcomes in the Pharmacological Treatment of Psychiatric Issues

Joseph F. Goldberg, MD CME credit: 1.00

Get Started

From Unipolar to Bipolar (and Everything In Between): Identifying and Treating Depression Across the Entire Mood Disorders Spectrum

Andrew J Cutler, MD; Joseph F. Goldberg, MD CME credit: 1.00

Get Started

Bring Your “A” Game: Screening For and Treating Depression With Mixed Features

Manpreet K Singh, MD, MS CME credit: 0.75

Get Started

Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders

Roger McIntyre, MD, FRCPC CME credit: 1.00

Get Started

If You Musc: Modulation of Muscarinic Receptors in the Treatment of Schizophrenia

Hara Ella Oyedeji, CRNP, PMHNP, MSN, MED CME credit: 1.00

Get Started

Outside the Box: Upstream Muscarinic Modulation of Downstream Dopamine

Jonathan M Meyer, MD CME credit: 1.00

Get Started

1 2 3 4 5 6 7 8 9 10 ...

In Everyone’s Best Interest: Protecting Patients and Prescribers from the Consequences of Neglected Tardive Dyskinesia

Not Your Grandpa’s Antipsychotic: Optimizing Treatment for Schizophrenia Utilizing Novel Muscarinic Treatment Strategies

A More Tailored and Swift Approach? Using Clinical Endophenotypes to Address Major Depressive Disorder in All of Its Variations

Musc-y With a Chance of Glu: Advances in Our Understanding of Cortical Networks Involved in Cognitive Impairment Associated With Schizophrenia

Putting a SDA-PA to “Antipsychotic” Nomenclature: Improving Patient Engagement and Outcomes in the Pharmacological Treatment of Psychiatric Issues

From Unipolar to Bipolar (and Everything In Between): Identifying and Treating Depression Across the Entire Mood Disorders Spectrum

Bring Your “A” Game: Screening For and Treating Depression With Mixed Features

Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders

If You Musc: Modulation of Muscarinic Receptors in the Treatment of Schizophrenia

Outside the Box: Upstream Muscarinic Modulation of Downstream Dopamine

Not A Member?